## GL: Globe Life Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -1.2% below STRENGTH zone (4.0-10.0%); PEG 1.68 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($127.51)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Bronstein, Gewirtz & Grossman, LLC Is Investigating Globe Life Inc. (GL) And Encourages Stockholders to Connect**
- Source: FourStatesHomepage.com | 20251130T110000 | Neutral | Relevance: 99%
- Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Globe Life Inc. (GL). The law firm encourages investors who purchased Globe Life securities prior to May 8, 2019, and still hold them, to contact them to assist with the investigation. The firm operates on a contingency fee basis, meaning there is no cost to investors unless they are successful in recovering funds.

**2. Bronstein, Gewirtz & Grossman, LLC Is Investigating Globe Life Inc. (GL) And Encourages Stockholders to Connect**
- Source: CIProud.com | 20251130T160000 | Neutral | Relevance: 99%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. (NYSE:GL) securities. The investigation focuses on whether Globe Life and certain officers engaged in corporate wrongdoing, specifically for investors who purchased securities prior to May 8, 2019, and continue to hold them. The firm encourages affected stockholders to connect to assist with the investigation, emphasizing that there is no cost to them unless the firm is successful in recovering funds.

**3. Bronstein, Gewirtz & Grossman, LLC Is Investigating Globe Life Inc. (GL) And Encourages Stockholders to Connect**
- Source: ACCESS Newswire | 20251130T110000 | Neutral | Relevance: 98%
- Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into potential corporate wrongdoing by Globe Life Inc. (NYSE:GL). The firm is encouraging stockholders who purchased Globe Life securities before May 8, 2019, and still hold them, to connect and assist with the investigation. The investigation focuses on whether Globe Life and its officers/directors engaged in illegal activities.

**4. Bronstein, Gewirtz & Grossman, LLC Is Investigating Globe Life Inc. (GL) And Encourages Stockholders to Connect**
- Source: WRIC ABC 8News | 20251130T110000 | Neutral | Relevance: 98%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. (NYSE:GL). The investigation focuses on whether Globe Life and certain officers engaged in corporate wrongdoing, particularly for investors who purchased securities prior to May 8, 2019. The firm encourages affected stockholders to connect to assist with the investigation.

**5. Bronstein, Gewirtz & Grossman, LLC Is Investigating Globe Life Inc. (GL) And Encourages Stockholders to Connect**
- Source: WTAJ | 20251130T110000 | Neutral | Relevance: 98%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. (NYSE:GL) securities who bought prior to May 8, 2019, and still hold them. The investigation focuses on whether Globe Life and its officers/directors engaged in corporate wrongdoing. The firm encourages affected stockholders to contact them for more information at no cost.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | Morgan Stanley | $177 | $179 | -1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.24M) |
| Sells | 1 ($5.38M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.6% (-2.7%)
- Blackrock Inc.: 7.2% (-2.1%)
- Invesco Ltd.: 4.8% (-1.9%)
- State Street Corpora: 4.1% (-3.5%)
- Wellington Managemen: 3.5% (-29.0%)

### Key Risks

1. Insider selling cluster: $5.4M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.68 elevated, pricing in significant growth expectations. Forward P/E 8.8x stretched relative to 3% growth. Quality metrics strong (ROE 22%, margin 19%). Balance sheet: strong liquidity (2.8x). Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($5.4M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 8 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $10.9B |
| Beta | 0.48 |
| 52W Range | $102.44 - $147.83 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.68 |
| Forward P/E | 8.8 |
| Current P/E | 9.1 |
| YoY Growth | 2.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.9% to -1.2% (-3.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.2pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.02x) but short-term weakness (below SMA20). RSI neutral at 46.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.17% (CS: 36) | Neutral |
| RSI_14 | 46.3 | Neutral |
| MACD Histogram | 0.43 | Bullish |
| vs SMA20 | 0.999x | Below |
| vs SMA50 | 0.977x | Below |
| vs SMA200 | 1.024x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $132.53
- **Stop Loss:** $127.51 (3.8% risk)
- **Target:** $137.55 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 199
- **Position Value:** $26,373.47
- **Portfolio %:** 26.37%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-02-04 (Est: $3.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.54 | $4.81 | +5.9% |
| 2025Q2 | $3.25 | $3.27 | +0.8% |
| 2025Q1 | $3.24 | $3.07 | -5.2% |
| 2024Q4 | $3.12 | $3.14 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*